Groundbreaking research published in The Lancet suggests that most people who believe they’re sensitive to gluten are ...

NASP data highlight reduction in disease burden among people living with uncontrolled goutGamifant (emapalumab) data showed response rates in ...

A single-number metric from a handheld device outperformed dozens of other measurements for the prediction of ...

Baron Health Care Fund gained for the quarter and outperformed its benchmark, the Russell 3000 Health Care Index. Read more ...

Patel discusses the design and patient criteria for the pivotal C-POST trial evaluating adjuvant cemiplimab in high-risk ...

(NASDAQ:MRNA) today announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the ...

Novartis AG ( NYSE: NVS) M&A Call October 27, 2025 8:00 AM EDT ...

Cambridge: Moderna, Inc. has announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the ...

Study adds to existing literature that shows damaging impact of obesity-related conditions on large portions of US population ...

Questionnaire identifies whether a respondent experiences food noise and the magnitude of it Measure is designed to support ...

With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.

Macrobond, the leading provider of global economic and financial data and analytics, today announced a strategic integration with FactSet, a global digital platform and enterprise solutions provider.